glp-1 in development What is the pipeline for future medications for obesity? Current Insights, Advantages and Challenges

Ozempic Use Linked to Blood Clots and Deep Vein Thrombosis (DVT) Study Highlight: Comprehensive analysis of the safety of semaglutide in type 2 diabetes: a meta-analysis of the SUSTAIN and PIONEER trials A study published in the Endocrine Journal in June 2021 found that semaglutide users had a 266% increased risk of developing DVT

[DOI] [PMC free article] [PubMed] [Google Scholar] 37.Farrs J., Pujol A., Coma M., Ruiz J.L., Naval J., Mas J.M., Molins A., Fondevila J., Aloy P

Just remarkable, long-lasting results in as little as one treatment

One-third of the participants lost at least 20% of their starting weight

Your Rights You have the right to:Request access to the personal information we hold about you Request correction of inaccurate information Request deletion of your personal information, subject to legal and medical record retention requirements Opt out of SMS communications at any time by replying STOP Opt out of email communications by clicking the unsubscribe link in any email 12

Syneos Health Sector: Clinical R&D HQ: Morrisville, NC Year Founded: 1999 Key Leaders: Costa Panagos, CEO